Arbutus Biopharma Corp. (ABUS)
4.20
-0.05
(-1.18%)
USD |
NASDAQ |
Apr 24, 16:00
4.20
0.00 (0.00%)
After-Hours: 16:22
Arbutus Biopharma Total Liabilities (Quarterly) : 18.04M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Moderna, Inc. | 3.688B |
| Merck & Co., Inc. | 84.20B |
| Pfizer Inc. | 121.38B |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 94.62M |
| Shareholders Equity (Quarterly) | 76.58M |
| Debt to Equity Ratio | 0.0547 |
| Current Ratio | 15.73 |
| Net Debt Paydown Yield | 0.06% |